BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 38370361)

  • 1. Growth disorders caused by variants in epigenetic regulators: progress and prospects.
    Lui JC
    Front Endocrinol (Lausanne); 2024; 15():1327378. PubMed ID: 38370361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic signatures in overgrowth syndromes: Translational opportunities.
    Cytrynbaum C; Choufani S; Weksberg R
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):491-501. PubMed ID: 31828978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Causes of Overgrowth Syndromes.
    Lui JC; Baron J
    J Clin Endocrinol Metab; 2024 Jan; 109(2):312-320. PubMed ID: 37450557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic syndromes caused by mutations in epigenetic genes.
    Berdasco M; Esteller M
    Hum Genet; 2013 Apr; 132(4):359-83. PubMed ID: 23370504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisulphite Sequencing of Chromatin Immunoprecipitated DNA (BisChIP-seq).
    Stirzaker C; Song JZ; Statham AL; Clark SJ
    Methods Mol Biol; 2018; 1708():285-302. PubMed ID: 29224150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects.
    Fahrner JA; Bjornsson HT
    Hum Mol Genet; 2019 Nov; 28(R2):R254-R264. PubMed ID: 31595951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation in cell reprogramming revealed by genome-wide analysis.
    Hong CP; Park J; Roh TY
    Epigenomics; 2011 Feb; 3(1):73-81. PubMed ID: 22126154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox Components: Key Regulators of Epigenetic Modifications in Plants.
    R M SK; Wang Y; Zhang X; Cheng H; Sun L; He S; Hao F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can clinical immunology learn from inborn errors of epigenetic regulators?
    Camacho-Ordonez N; Ballestar E; Timmers HTM; Grimbacher B
    J Allergy Clin Immunol; 2021 May; 147(5):1602-1618. PubMed ID: 33609625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of epigenetic mechanisms in cancer.
    Maleszewska M; Wojtas B; Kamińska B
    Postepy Biochem; 2018 Oct; 64(2):148-156. PubMed ID: 30656897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic mechanisms in paediatric brain tumours: regulators lose control.
    Badodi S; Marino S
    Biochem Soc Trans; 2022 Feb; 50(1):167-185. PubMed ID: 35076654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation in Drosophila.
    Lyko F; Beisel C; Marhold J; Paro R
    Curr Top Microbiol Immunol; 2006; 310():23-44. PubMed ID: 16909905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crosstalk between m
    Zhao Y; Chen Y; Jin M; Wang J
    Theranostics; 2021; 11(9):4549-4566. PubMed ID: 33754077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin Structure and Dynamics: Focus on Neuronal Differentiation and Pathological Implication.
    Nothof SA; Magdinier F; Van-Gils J
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
    Sahafnejad Z; Ramazi S; Allahverdi A
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic dynamic during endochondral ossification and articular cartilage development.
    Allas L; Boumédiene K; Baugé C
    Bone; 2019 Mar; 120():523-532. PubMed ID: 30296494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes.
    Symeonidis A; Chatzilygeroudi T; Chondrou V; Sgourou A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Regulation of Chromatin in Prostate Cancer.
    Natesan R; Aras S; Effron SS; Asangani IA
    Adv Exp Med Biol; 2019; 1210():379-407. PubMed ID: 31900918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.